Head and Neck Cancer
Showing NaN - NaN of 115
Head Neck Cancer Trial in United States (NYU Electronic Patient Visit Assessment (ePVA), Usual Care)
Not yet recruiting
- Head and Neck Cancer
- NYU Electronic Patient Visit Assessment (ePVA)
- Usual Care
-
Kansas City, Kansas
- +4 more
Sep 1, 2023
Lymphedema of Face, Head Neck Cancer Trial in Houston (Near-infrared fluorescence lymphatic imaging, advanced pneumatic
Not yet recruiting
- Lymphedema of Face
- Head and Neck Cancer
- Near-infrared fluorescence lymphatic imaging
- advanced pneumatic compression therapy
-
Houston, TexasThe University of Texas Health Science Center at Houston
Jun 29, 2023
Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified
Recruiting
- Endometrial Cancer
- +8 more
- Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
-
Orlando, Florida
- +21 more
Feb 2, 2023
Head Neck Cancer Trial in Houston (Quality of Life Survey, Health Management Surveys, Monitoring Devices)
Active, not recruiting
- Head and Neck Cancer
- Quality of Life Survey
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 19, 2022
Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single
Recruiting
- Advanced Solid Tumor
- +7 more
- PY159 Single agent dose level 1
- +17 more
-
San Francisco, California
- +11 more
Nov 3, 2022
Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in New
Completed
- Head and Neck Cancer
- +2 more
- ADXS11-001 (ADXS-HPV)
-
New York, New York
- +1 more
Sep 9, 2022
Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial in Houston (18F-FSPG, 11C-Glutamine)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Head and Neck Cancer
-
Houston, TexasM D Anderson Cancer Center
Sep 14, 2022
Squamous Cell Carcinoma, Oropharynx Cancer, Head Neck Cancer Trial in Houston (SAR444245, Cemiplimab)
Not yet recruiting
- Squamous Cell Carcinoma
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 7, 2022
Head Neck Cancer Trial in Houston, Shanghai (Questionnaires, Acupuncture, Electroencephalogram (EEG))
Completed
- Head and Neck Cancer
- Questionnaires
- +2 more
-
Houston, Texas
- +1 more
Aug 30, 2022
Head Neck Cancer Trial in Houston (Computerized Tasks, Questionnaires)
Active, not recruiting
- Head and Neck Cancer
- Computerized Tasks
- Questionnaires
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 18, 2022
Head And Neck Cancer Trial in Houston (Minocycline, Placebo, Questionnaires)
Completed
- Head And Neck Cancer
- Minocycline
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 16, 2022
Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)
Recruiting
- Advanced Solid Tumor
- +18 more
- PT199
- Anti-PD-1 monoclonal antibody
-
Huntersville, North Carolina
- +2 more
Aug 10, 2022
Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)
Recruiting
- Endometrial Neoplasms
- +3 more
- COM701 in combination with BMS-986207 and nivolumab.
-
Chicago, Illinois
- +8 more
Aug 8, 2022
Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T
Active, not recruiting
- Urinary Bladder Cancer
- +9 more
- Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
- Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
-
Miami, Florida
- +10 more
Aug 9, 2022
Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)
Active, not recruiting
- Metastatic Cancer
- +9 more
-
Mobile, Alabama
- +19 more
Aug 1, 2022
Radiation-Induced Xerostomia, Head Neck Cancer, Radiation Toxicity Trial in United States (Standard Oral Hygiene, Standard Oral
Completed
- Radiation-Induced Xerostomia
- +3 more
- Standard Oral Hygiene
- +2 more
-
Burbank, California
- +35 more
Jul 29, 2022
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022
